Hamilton Lane Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Hamilton Lane Advisors’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-36,974	Closed	-$1.25M	–	102
2021 Q2	$1.25M	Buy	+36,974	New	+$942K	0.39%	47
2020 Q4	–	Sell	-54,771	Closed	-$1.11M	–	63
2020 Q3	$1.11M	Buy	+54,771	New	+$1.34M	0.54%	28
2020 Q2	–	Sell	-69,022	Closed	-$2.17M	–	50
2020 Q1	$2.17M	Buy	+69,022	New	+$2.4M	1.26%	17

Hamilton Lane Advisors's CNST Position: Q3 2021 in Review

Hamilton Lane Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 36,974 shares — an estimated $1.25M sold.

Hamilton Lane Advisors first reported a position in CNST in Q1 2020 and held it in 3 quarters. The position peaked at $2.17M in Q1 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Hamilton Lane Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Hamilton Lane Advisors sold 36,974 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.25M.
Hamilton Lane Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
Hamilton Lane Advisors's Constellation Pharmaceuticals, Inc. position peaked at $2.17M in Q1 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Hamilton Lane Advisors's 13F filing for Q3 2021, filed 14 Oct 2021.